Next Article in Journal
Dark Chocolate Intake Positively Modulates Gut Permeability in Elite Football Athletes: A Randomized Controlled Study
Next Article in Special Issue
Post-Exercise Protein Intake May Reduce Time in Hypoglycemia Following Moderate-Intensity Continuous Exercise among Adults with Type 1 Diabetes
Previous Article in Journal
Winter Holidays and Their Impact on Eating Behavior—A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 15
Issue 19
10.3390/nu15194202
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function

by
Emanuela Di Murro
1,2,†,
Gianfranco Di Giuseppe
1,2,†,
Laura Soldovieri
1,2,
Simona Moffa
1,2,
Ilaria Improta
1,2,
Umberto Capece
1,2,
Enrico Celestino Nista
2,3,
Francesca Cinti
1,2,
Gea Ciccarelli
1,2,
Michela Brunetti
1,2,
Antonio Gasbarrini
2,3,
Alfredo Pontecorvi
1,2,
Andrea Giaccari
1,2,* and
Teresa Mezza
2,3,*
1
Endocrinologia e Diabetologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy
2
Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
3
Pancreas Unit, CEMAD Centro Malattie dell’Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2023, 15(19), 4202; https://doi.org/10.3390/nu15194202
Submission received: 7 September 2023 / Revised: 24 September 2023 / Accepted: 27 September 2023 / Published: 28 September 2023
(This article belongs to the Special Issue Effects of Activity Type and Dietary Management on Glycemic Balance)
Versions Notes

Abstract

:
Type 2 diabetes mellitus (T2DM) is one of the most widespread diseases worldwide. Lifestyle interventions, including diet and physical activity (PA), are fundamental non-pharmacological components of T2DM therapy. Exercise interventions are strongly recommended for people with or at risk of developing or already with overt diabetes, but adherence to PA guidelines in this population is still challenging. Furthermore, the heterogeneity of T2DM patients, driven by differing residual β-cell functionality, as well as the possibility of practicing different types and intensities of PA, has led to the need to develop tailored exercise and training plans. Investigations on blood glucose variation in response to exercise could help to clarify why individuals do not respond in the same way to PA, and to guide the prescription of personalized treatments. The aim of this review is to offer an updated overview of the current evidence on the effects of different regimens and modalities of PA regarding glucose sensing and β-cell secretory dynamics in individuals with prediabetes or T2DM, with a special focus on β-cell function.

1. Introduction

T2DM is a chronic metabolic disorder characterized by high glucose levels, driven by the disruption of the physiologic balance between tissue sensitivity to insulin action, changes in plasma glucose and insulin secretion, β-cell function, and mass. In particular, impairments in β-cell function [1,2] can affect the dynamics of insulin secretion even at a very early stage of the disease [3,4]. The increased morbidity and mortality in T2DM patients [5] can be mostly ascribed to metabolic dysregulation and chronic inflammation leading to atherosclerotic cardiovascular disease (ASCVD). Lifestyle interventions, including appropriate diet and physical activity (PA), constitute an important non-pharmacological aspect of T2DM therapy, and their effectiveness in the prevention of T2DM-associated ASCVD has been amply demonstrated [6]. PA improves glycemic control [7] in patients with diabetes by enhancing insulin secretion and insulin sensitivity [8,9], and by stimulating glucose uptake by skeletal muscle and reducing body weight against a background of poor β-cell function. In addition, PA may counter inflammation related to pancreatic β-cell dysfunction [10] via circulating mediators, reducing oxidative stress and increasing the levels of antioxidants [11,12,13]. In this regard, some meta-analyses have shown that aerobic training, resistance training, and the combination of the two improve glycemic control and HbA1c levels [14,15,16], together with significant improvements in anthropometric, cardiovascular, and metabolic risk factors [16,17]. Other studies have found associations between PA and diabetes remission rate in newly diagnosed subjects [18,19,20]. Anyway, it should be underlined that improvements in glucose tolerance and glucose homeostasis were only achieved through PA in combination with pharmacologic treatment and/or an appropriate dietary regimen in these studies, providing evidence that PA is a necessary, but not sufficient, strategy for achieving partial or complete remission from the disease.
The European Society of Cardiology (ESC) Task Force on sport cardiology and exercise has suggested that adults with diabetes should exercise for at least 5–7 days/week with 30 min/day of moderate or vigorous aerobic activity together with 15 min of resistance training. This should preferably be spread throughout the week, with no more than two consecutive days of inactivity, to achieve the best impact on glucose homeostasis [21] and on cardiorespiratory fitness and body composition, with major changes in body fat mass [22]. In addition, the recently published update to the Position Statement on Exercise and T2DM by the American College of Sports Medicine (ACSM) and the ADA [23] has summarized new evidence on the different modalities and intensities of PA, underlining that a “one-size-fits-all” exercise prescription based only on aerobic activity and the possible association of resistance activity is no longer feasible. Although the metabolic benefits of exercise are relevant, its effects are short-lived and begin to fade within 48 h [21,24]; thus, the need for a strategy to maintain the metabolic setting achieved through exercise is evident. Moreover, there is still controversy as to the type of PA that is most effective in controlling glucose metabolism.
The aim of this review is to summarize the current evidence on different types of PA and their effects on β-cell function and metabolic control in individuals with prediabetes or overt diabetes, considering that the beneficial effect of exercise includes improvements in tissue sensitivity to glucose and insulin, as well as insulin content and/or insulin secretion. Specifically, we will focus on the interrelationship between PA and changes in β-cell function.

2. Evidence Acquisition

The literature search was performed, in duplicate and independently, by two authors (EDM and GDG) through the PubMed database, focusing on exercise intervention in individuals with type 2 diabetes. The initial search included the following MeSH term combination: diabetes mellitus type 2, physical activity, exercise, β-cell function, hyperglycemia, training, and metabolic dysfunction. Titles and abstracts from the literature search were independently evaluated by three investigators (EDM, GDG, and TM). Only eligible full texts in the English language, like scientific papers, clinical trials, meta-analyses, and reviews published up to August 2023, were considered. Case reports and series were excluded. The literature search was limited to human studies.

3. Effects of Physical Activity on β-Cell Function and Insulin Secretion

Insulin resistance and β-cell dysfunction are fundamental metabolic defects of T2DM, and these conditions are already partially present in obese subjects with prediabetes [25]. The preservation of residual β-cell function in individuals with obesity and IGT—who have already lost up to 50–70% of β-cell function—is an effective strategy to prevent T2DM [26,27]. The mechanism linking PA and β-cell function is still not fully understood; however, it has been demonstrated that exercise interventions and correct dietary management may protect β-cell function by reducing metabolic stress [28]. Exercise training has a potential role in preserving β-cell health, and, therefore, represents an effective strategy to prevent or delay diabetes onset in individuals at risk of or already affected by the disease; moreover, PA supports pharmacological effectiveness to prevent β-cell failure [10].
It can be difficult to estimate the relative contribution of a single type of PA to β-cell protection, as well as the correct timing for exercise interventions in patients with metabolic impairments, but there is evidence that exercise, when started at an early stage, may delay disease progression by increasing β-cell resistance to endoplasmic reticulum (ER) stress [29] and other mediators of immune damage [10]. Several trials have studied the effect of exercise on insulin secretion in individuals with T2DM and prediabetes [8,9,30,31,32,33,34,35,36,37], as well as in sedentary overweight or obese subjects [8,35,36,38,39,40,41]. Some of these studies have investigated the effects of different intensities of aerobic training [8,9,30,32,34,35,36,37,40], while others have evaluated high-intensity interval training (HIIT) [42,43], resistance training [31,36], and simultaneous aerobic and resistance training or a combination of the two [38,39,41] on metabolic outcomes (Table 1). Slentz et al. [40], in the STRRIDE project, evaluated the effects of different intensities and different amounts of exercise on the Disposition Index (DI) in an 8-month intervention program in people with T2DM. The DI represents the product of measures of insulin sensitivity and the acute insulin response to glucose (AIRg, an index of first-phase insulin secretion), thus expressing the ability of β-cells to compensate for augmented insulin resistance with changes in the first-phase secretion [44]. This index has been shown to decrease with the deterioration of glucose tolerance, as well as to predict diabetes onset independently of fasting and 2 h plasma glucose levels after an oral glucose tolerance test (OGTT) [45,46]. The STRRIDE study demonstrated that moderate and vigorous intensity exercise improved β-cell function through distinct mechanisms in sedentary overweight adults. A high amount of exercise and exercise of vigorous intensity were associated with an improvement in insulin sensitivity and a compensatory decrease in insulin secretion, while a low amount of exercise and moderate-intensity exercise were associated only with a comparable improvement in insulin sensitivity. Moreover, moderate exercise led to greater improvements in β-cell function, while vigorous exercise was superior in terms of achieving improvements in cardiorespiratory fitness. Further, to investigate the effects of aerobics, resistance training, and their combination on insulin sensitivity and insulin secretion, an intravenous glucose tolerance test (IVGTT) was performed in the STRRIDE cohort [41] at baseline, at the end of exercise training (16–24 h after the last exercise) and 14 days after the end of exercise training. This analysis demonstrated that the combination of aerobic (AT) and resistance training (RT) led to greater improvements in insulin sensitivity, DI, and glucose effectiveness compared to AT or RT alone. In particular, a greater improvement in β-cell function was found in people with T2DM compared to normal, glucose-tolerant (NGT) subjects [47].
In conclusion, in the cited trials, it is important to note that only interventions lasting more than 2 months resulted in improvements in insulin secretion, and that all training regimens led to benefits regarding insulin secretion. This emphasizes that significant results can only be achieved following an appropriate exercise program, whereas random exercise sessions might not result in significant improvements in glucose metabolism or cardiovascular outcomes.

4. Responsiveness to Physical Activity

Despite the well-recognized positive impact of PA on β-cell function and insulin secretion, individuals with different secretory functions at baseline may show different responses to interventions, and a variable proportion of patients have been described as exercise resistant in several studies. Dela et al. [9] stratified patients with T2DM into “moderate” and “low” secretors according to individual C-peptide responses to an intravenous glucagon test. They found that only moderate secretors obtained positive responses from an aerobic training program, thus highlighting that a residual β-cell secretory capacity is required in order to maximize the beneficial effect of aerobic exercise on glycemic control. In addition, to further investigate how baseline β-cell function may influence training-induced changes in glycemic control, the HERITAGE study [34] assessed insulin secretion patterns during an IVGTT in a large heterogenic population to detect possible differences in β-cell functional effects in response to a 20-week endurance training program (cycle ergometers 3 days/week for 60 sessions). Participants with better glucose tolerance at baseline showed reduced insulin secretion following regular exercise, while those with poorer glucose tolerance at baseline showed an increase in insulin secretion after exercise. These results suggest that intersubject variability in baseline β-cell function could partially explain the different effects of exercise on glucose homeostasis. In this context, intersubject variability in basal insulin secretion could provide an effective explanation for the different secretory responses to exercise and should be considered when prescribing tailored and individualized treatments. Consistently, another study confirmed this variability by demonstrating that long-term exposure to hyperglycemia –leading to reduced β-cell function [48] and low insulin secretory function—before the introduction of PA predict a poorer training-induced outcome. Thus, aerobic exercise may be less effective in improving glucose control in patients with poorly controlled long-term T2DM. Accordingly, another study [36] confirmed that the response to exercise in prediabetic and diabetic subjects largely depends on basal β-cell function: in particular, basal HbA1c, BMI, and β-cell function were all predictors of exercise response in elderly patients with prediabetes; by contrast, the type of PA did not predict the effectiveness of the response. In this context, residual β-cell function should be restored through appropriate pharmacological treatment by eliminating the noxious effects of gluco- and lipotoxicity before therapeutic aerobic exercise can provide effective improvements in glucose homeostasis. Collectively, these data strongly support the need for individualized treatments in order to maximize the benefit of exercise.
A recent study [18] investigated the effectiveness of a 12- or 24-month intensive lifestyle program in inducing partial or complete T2DM remission compared to standard of care, demonstrating that 23% of participants in the lifestyle intervention group met the criteria for any T2DM remission compared to 7% in the standard care group. Further, the highest remission rate was obtained in participants with well-controlled short-duration T2DM. Similarly, a 6-month exercise and weight loss program, which included 45–60 min sessions/week of supervised on-site exercise and home walking on other days for a total of 5–6 days per week of exercise in newly diagnosed and drug-naïve T2DM individuals, [19] induced partial remission in 80% of subjects who completed the program.
In the LookAHEAD study [20], individuals with a median T2DM duration of 5 years were randomized to an intensive lifestyle-based weight loss intervention (ILI) aimed at reducing total caloric intake by limiting total and saturated fat intake and increasing PA up to 175 min/week, or a Diabetes Support and Education intervention (DSE). The results showed that time since diagnosis, baseline HbA1c, and amount of weight loss were independent predictors of T2DM remission. Moreover, in the PLIS study [49], 908 individuals with prediabetes were stratified into low-risk or high-risk phenotypes based on insulin secretion, insulin resistance, and liver fat content. Low-risk patients were randomly assigned to conventional lifestyle intervention (eight lifestyle intervention sessions spread out over one year, in which they were advised to perform 3 h of exercise weekly) or no lifestyle intervention. On the other hand, high-risk individuals were assigned to conventional or intensified lifestyle interventions, with double the amount of exercise, i.e., 16 one-to-one coaching sessions. Over the 3-year follow-up period, the intensified lifestyle intervention in high-risk individuals proved to be more effective in normalizing glucose tolerance.
Collectively, these results confirm the importance and the effectiveness of exercise as an early treatment for T2DM patients. Moreover, the exercise prescription needs to be personalized, aiming at diabetes prevention or remission on the basis of risk phenotype. Further investigations on the effectiveness of different types of exercise on β-cell function in the heterogeneous T2DM population are therefore necessary.

5. Exercise Regimens for T2DM

As shown in Table 2, many types of PA can improve glycemic control and lead to overall benefits in people with T2DM. To date, aerobic and resistance training, and the combination of both, have formed the cornerstone of lifestyle intervention for T2DM patients, as previously mentioned. Aerobic training, like running and cycling for about 1 h, is a moderate-intensity type of PA and represents the best activity to reduce body fat mass when required. Moreover, it leads to improvements in oxygen transport and metabolism in the skeletal and heart muscle [50]. Resistance training, on the other hand, is strength-building, as it increases lean body mass, and is characterized by short-term exercise repetitions performed by using, for example, external resistance tools like dumbbells, kettlebells, and barbells, or using body weight, weight machines, or elastic resistance bands.
Many studies have investigated the effects of different training regimens and their combinations on glucose homeostasis, lipid profile, blood pressure, and other metabolic and fitness parameters [51], as well as their anti-inflammatory activity [52] in prediabetic [53] and diabetic [22,54,55] patients, with or without weight loss. Among these, the HART-D [22] and DARE [56] trials have aimed at studying possible changes in HbA1c levels resulting from aerobic training, resistance training, and the combination of both in T2DM adults. The DARE study demonstrated significant improvements in glycemic control in the whole population, with a greater reduction in HbA1c in the combined exercise group compared to resistance and aerobic training alone, and these effects were greater in individuals with poor glycemic control at baseline. However, since the study design envisaged longer exercise durations for the combination group compared to the other two groups, this could partially influence the improvements observed in the combined exercise group. In contrast, the training programs in HART-D were designed to maintain similar weekly training times among groups, and the improvements in HbA1c levels were lower in the DARE population. This could, however, be due to the longer diabetes duration in HART-D trial participants, with 18.3% of the subjects on active insulin treatment (while insulin treatment was an exclusion criterion in DARE), or to the higher female population. Moreover, Cuff et al. [57], in a small population of 28 postmenopausal, obese, and diabetic women, randomized them to three exercise types (aerobic, resistance, or combination training) for 4 months and demonstrated that combined training elicited significant enhancement in insulin sensitivity compared to the control group. It seemed to be more successful in improving insulin resistance than aerobic training alone, while no changes in HbA1c levels were observed, probably due to the small cohort which was enrolled.
Indeed, in a systematic review by Schwingshackl et al. [58], aerobic and combined training were found to be more effective in reducing HbA1c compared to resistance training alone. In particular, the combined training produced a significantly greater reduction in HbA1c and fasting glucose, as well as improvements in lipid and blood pressure profiles compared to aerobic or resistance training alone.
Despite the major effects of improving joint range of motion; reducing the risk of falls, especially in adults with peripheral neuropathy; and facilitating participation in other activities, trials investigating the effects of flexibility and balance exercises, alone or in combination with resistance training, showed no significant impact on glucose control [59,60,61]. In addition, Pilates and yoga [62,63,64], considered alternative training regimens for individuals with lower levels of fitness and poorer balance, also demonstrated improvements in postprandial glycemia after 4 weeks and in HbA1c levels after 12 weeks of treatment in older women with T2DM who underwent 12 weeks of Pilates training (60 min per session/3 times per week). Similarly, two recent meta-analyses reviewed the efficacy of yoga in adults with T2DM [63,64], concluding that yoga significantly improves glycemic outcomes such as fasting and postprandial blood glucose as well as Hb1Ac levels, lipid profile, and blood pressure.
Recently, high-intensity interval training (HIIT) has been developed as a new PA protocol. It consists of the repetition of short intervals of aerobic training (running or cycling), performed between 75–95% of peak heart rate, alternating with short periods of active or passive recovery. In a recent metanalysis, Jelleyman et al. [65] aimed to quantify the effect of HIIT on markers of glucose regulation and insulin resistance compared with controls or continuous training, and concluded that participants in HIIT groups had a 0.19% reduction in HbA1c and a 1.3 kg reduction in body weight compared to control groups with interventions lasting at least 2 weeks. However, significant intrasubject heterogeneity to exercise responsiveness in terms of glycemic control and β-cell function was observed in a group of T2DM patients after 8 weeks of low-volume HIIT, thus stressing the need to personalize exercise treatments. Similarly, functional high-intensity training (F-HIT) is a supervised training protocol of 10–20 min/session 3 times a week, characterized by various functional movements (based on real-world situational exercises) at a high intensity, combining resistance training, gymnastics (body weight), and aerobic exercise. F-HIT was found not only to be a time-efficient modality with which to improve fitness levels, insulin sensitivity, and pancreatic β-cell function in adults with T2DM [43], but also to reduce the risk of metabolic syndrome [66]. Fealy et al. [67] recently demonstrated the benefits of this activity protocol on β-cell function in people with T2DM, showing that F-HIT is effective in improving insulin sensitivity and reducing cardiometabolic risk in overweight or obese adults with T2DM. In particular, F-HIT exercise led to reductions in fat mass, plasma triglycerides and cholesterol, metabolic syndrome severity, diastolic blood pressure, and concentrations of plasma resistin—a pro-inflammatory adipokine. A recent review has indeed highlighted how only high-intensity physical exercise improves metabolic control at the musculoskeletal level, possible due to the release of myokines, fatty acids, and/or the activation of specific β-cellular receptors for fatty acids [68]. In addition, another study investigating the effects on beta-cell function suggested that F-HIT significantly increased the DI, while no changes in the OGTT-derived first- and second-phase insulin secretion were observed after intervention [43]. In summary, compared to other types of exercise, and with a minimal time commitment, F-HIT and HIIT can be considered as safe and effective training approaches, leading to improvements in β-cell function in adults with T2DM with preserved residual β-cell secretory capacity and with no contraindications.

6. Adherence and the “Lack of Time”

Currently, there are many lifestyle-related obstacles to the achievement of the minimum recommended PA levels. One of the main barriers to adherence is “lack of time” [69]. Guidelines advocate at least 5 h of aerobic, resistance, and flexibility training spread out over 5 days per week, but compliance and adherence to these recommendations is very low; in fact, only 10–23% of people adhere to these recommendations in the USA [70]. In addition, the estimation of PA, using a structured 7-day physical activity recall interview in medically treated T2DM individuals with atherosclerotic cardiovascular disease or with cardiovascular risk factors, revealed that fitness levels were very low and almost half the participants failed to reach the minimum PA recommendation levels [71]. In this context, “lack of time” represents one of the main reasons for non-adherence to therapeutic exercise programs. Thus, additional efforts are needed in order to promote greater adherence to guidelines by prescribing tailored PA programs. In addition, it should be considered that the extent of the beneficial effects—such as the improvement of glucose homeostasis and the reduction in cardiometabolic risk factors in people with diabetes—is dependent on the total energy expenditure of training rather than exercise duration or intensity [72,73]. In particular, the American College of Sports Medicine (ACSM) recommends that T2DM patients undergo at least 1000 kcal/week of energy expenditure and that men and women expend between 1000 and 2000 kcal/week to obtain cardiometabolic benefits [23]. Therefore, new PA high-intensity exercise protocols (e.g., HIIT and F-HIT) have been studied as possible alternatives with which to improve adherence in people with a “lack of time”. High-intensity exercise protocols have been proposed as time-efficient methods to achieve cardio-metabolic health outcomes, equivalent to traditional aerobic training programs [74]. In addition, HIIT could be an effective protocol to use to meet the 1000–2000 kcal/week expenditure goal. In this regard, a study [37] investigated the relationship between exercise dose and pancreatic β-cell function in men and women with prediabetes. The exercise intervention consisted of a supervised aerobic exercise program of 50–60 min 5 days/week at 60–65% of the maximum heart rate (HR) for the first 4 weeks and, thereafter, the exercise intensity was increased and maintained at 80–85% HR. Moreover, the subjects also followed a controlled dietary regimen. The study showed that increasing the intensity of exercise can enhance β-cell function in adults with poor insulin secretion capacity, without any relationship to changes in body fat. In particular, the study showed that exercise interventions expending more than 2000 kcal/week increased pancreatic β-cell function in a linear dose–response manner and confirmed that a tailored exercise prescription with the correct intensity, duration, and modality is necessary to maximize energy expenditure and glucoregulatory effects. Similarly, Davis et al. [75] reported that that high-dose exercise, compared to low-dose exercise, enhanced first-phase β-cell function in overweight children.
To summarize, high-intensity exercise programs could be effective in reaching energy expenditure targets within the shortest possible time, thus increasing the rate of adherence to recommendations. However, this PA protocol should be prescribed only after a cardiovascular screening test—including resting ECG and maximal stress ECG testing—and only after accurate anamnesis, excluding congenital heart disease, ischemic heart disease, myocarditis, and arrhythmias, as well as any pathologic bone, joint, or muscle condition.
Among cardiovascular screening tests, cardiopulmonary exercise testing (CPET) is a non-invasive yet valuable screening tool that provides a comprehensive and multi-parametric assessment of the functioning of the cardiovascular, pulmonary, muscular, and even cellular systems during exercise. Several studies employing this type of test have highlighted specific cardiorespiratory alterations in patients with T2DM and without any overt pulmonary or cardiovascular disease. These alterations include reduced peak workload, peak oxygen uptake, oxygen pulse, and ventilatory efficiency [76].
Moreover, CPET has facilitated the identification of significant gender differences [77] in a fundamental parameter derived from the test, namely, peak oxygen uptake (VO2peak), which reflects functional capacity and cardio-circulatory efficiency. In the context of tailoring exercise prescriptions, it is essential to consider not only that a diabetic patient may exhibit a lower VO2peak value compared to a non-diabetic individual, but also that sedentary women with diabetes have a lower VO2peak compared to men with the same diagnosis.

7. Nutrition and Physical Activity

Together with PA, nutrition is another fundamental non-pharmacological milestone in T2DM therapy. Over the last years, many recommendations [78,79,80,81] have been put forth by scientific communities to help clinicians in the prescription of the most appropriate nutritional intervention in subjects with T2DM: in fact, by promoting weight loss and ameliorating insulin sensitivity, diet and PA together can lead to improved blood glucose and blood pressure profiles, as well lipid levels, with effectiveness for CV safety [82]. However, adherence in clinical practice seems to be generally poor [25], and more effort should be put in building combined and tailored nutritional/exercise plans to improve overall compliance. The study of food metabolism is complex, and its consequences on overall health depend on the interrelationships among nutrients and bioactive non-nutrients (antioxidants, fiber, minerals, etc.) rather than single nutrients alone; for these reasons, in recent decades, more emphasis has been put on the quality of one’s diet [83] and possible dietary patterns according to individual goals. The Mediterranean diet deserves special mention: it is characterized by the consumption of whole grain, legumes, fruits, vegetables, nuts, olive oil, and moderate intake of wine and meat, providing an important apport of vitamins, minerals, anti-oxidants, mono- and poly-unsaturated fatty acids, and fibers. It has recently been demonstrated to correlate with more favorable cardiovascular risk factors profile, better glucose control, and lower BMI [84].
In accordance with the 2020–2025 US Dietary Guidelines for Americans, a healthy eating plan should provide the appropriate daily caloric intake. It should emphasize the consumption of fruits, vegetables, and whole grains; include reduced or non-fat dairy products, lean meats, poultry, fish, beans, eggs, and nuts; and keep saturated and trans fats, cholesterol, salt, and added sugar intake low. A whole foods-based diet is rich in micronutrients and antioxidants, and is beneficial for preventing and managing T2DM [85]. In particular, a nutritional program for patients with T2DM undergoing an exercise regimen should be carefully planned to improve blood glucose levels and promote overall health. Typically, individuals with T2DM who engage in regular physical activity should focus on maintaining a proper carbohydrate balance by limiting foods with high glycemic indices. They should also incorporate sources of lean protein and fiber to enhance glycemic control, while opting for unsaturated fats.
Among all dietary approaches, carbohydrate restriction has been shown to reduce body weight and improve glycemia [25], and the use of popular diet options (i.e., low carbohydrate, ketogenic diet) and other eating patterns (i.e., Mediterranean, vegan) are frequently followed for T2DM management [86]. For example, a pilot study demonstrated the effectiveness of a very low-carbohydrate ketogenic diet in improving glucose control and weight in a group of overweight T2DM subjects compared to a standard low-fat diet [87]. Further strategies include intermittent fasting (IF) and fasting-mimicking diets (FMD) [88]. IF provides alternating periods of eating and fasting and time-restricted feeding, and is an effective method for weight and calorie intake management; FMD is a plant-based dietary regimen designed to obtain fasting-like metabolic effects. Both IF and FMD offer potential advantages, including weight loss and enhanced metabolic markers [25]. Furthermore, we have recently reviewed possible dietary strategies (including carbohydrate and glycemic index restriction, whey proteins, and meal timing) which lead to positive effects on β-cell function [3].
Recently, a potential correlation has been identified between nutrition timing and physical exercise. Specifically, PA performed in a fasted state by healthy individuals leads to greater improvements in insulin sensitivity compared to the same type of exercise performed in a different nutritional state [89]. This research, combined with the findings of a retrospective cohort study on the LookAHEAD population [20], which revealed that greater changes in HbA1c were independent of weekly training volume, but, rather, related to the time of day when physical activity occurred, marks the beginning of an intriguing frontier in scientific research regarding lifestyle interventions and circadian biology. This research has the potential to optimize the effectiveness of both pharmacological and non-pharmacological treatments for patients with type 2 diabetes mellitus [90].
Further investigations are necessary in order to explore the efficacy, compliance, long-term sustainability, metabolomic implications, and potential interactions of various nutritional strategies when combined with different patterns of physical activity on glucose homeostasis and β-cell function. Additionally, these investigations should consider their associations with pharmacological agents.

8. Conclusions

Future approaches to lifestyle intervention in patients with T2DM should certainly consider customized prescription of PA. A tailored training plan should be based on accurate phenotyping, which takes into account the type of diabetes, time since diagnosis, age, sex variabilities, and the presence of diabetes-related complications. Moreover, PA regimens should consider intrasubject variabilities driven by different residual β-cell function; in this scenario, the assessment of the disposition index could be an effective way to establish residual β-cell capacity. To date, considerable evidence has shown that the combination of aerobic and resistance training exerts major effects on glucose regulation in T2DM patients, as well as on the prevention of T2DM-associated ASCVD. However, alternative regimens, such as high-intensity exercise protocols, should be considered in selected patients to maximize the time-effectiveness of PA. Additional trials investigating the effects of exercise duration, intensity, and frequency on specific β-cell functional parameters are needed in order to personalize the doses and modes of exercise and lifestyle interventions to maximize the effect of PA on β-cell function and metabolic and cardiovascular outcomes.

Author Contributions

E.D.M. and G.D.G. wrote the manuscript. T.M., A.P. and A.G. (Andrea Giaccari) contributed to the discussion. T.M., A.P., A.G. (Andrea Giaccari), A.G. (Antonio Gasbarrini) and S.M. reviewed and edited the manuscript. S.M., I.I., U.C., E.C.N., G.C., L.S., M.B. and F.C. contributed to the discussion. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by grants from the Università Cattolica del Sacro Cuore (Fondi Ateneo Linea D.3.2, Fondi Ateneo Linea D.1, anno 2019, and Fondi Ateneo Linea D.1, anno 2020); the Italian Ministry of Education, University, and Research (MIUR) (GR-2018-12365577 to TM, RF-2019–12369293 to Andrea Giaccari and PRIN 2020SH2ZZA to Andrea Giaccari); the European Foundation for the Study of Diabetes award supported by Astra Zeneca and MIUR (to TM).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

The authors thank Serena Rotunno (Università Cattolica del Sacro Cuore) for editorial assistance with the writing of this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mezza, T.; Clemente, G.; Sorice, G.P.; Conte, C.; De Rose, A.M.; Sun, V.A.; Cefalo, C.M.A.; Pontecorvi, A.; Nuzzo, G.; Giaccari, A. Metabolic Consequences of the Occlusion of the Main Pancreatic Duct with Acrylic Glue after Pancreaticoduodenectomy. Am. J. Surg. 2015, 210, 783–789. [Google Scholar] [CrossRef] [PubMed]
  2. Mezza, T.; Shirakawa, J.; Martinez, R.; Hu, J.; Giaccari, A.; Kulkarni, R.N. Nuclear Export of FoxO1 Is Associated with ERK Signaling in β-Cells Lacking Insulin Receptors. J. Biol. Chem. 2016, 291, 21485–21495. [Google Scholar] [CrossRef] [PubMed]
  3. Di Giuseppe, G.; Ciccarelli, G.; Soldovieri, L.; Capece, U.; Cefalo, C.M.A.; Moffa, S.; Nista, E.C.; Brunetti, M.; Cinti, F.; Gasbarrini, A.; et al. First-Phase Insulin Secretion: Can Its Evaluation Direct Therapeutic Approaches? Trends Endocrinol. Metab. 2023, 34, 216–230. [Google Scholar] [CrossRef] [PubMed]
  4. Mezza, T.; Ferraro, P.M.; Di Giuseppe, G.; Moffa, S.; Cefalo, C.M.A.; Cinti, F.; Impronta, F.; Capece, U.; Quero, G.; Pontecorvi, A.; et al. Pancreaticoduodenectomy Model Demonstrates a Fundamental Role of Dysfunctional β Cells in Predicting Diabetes. J. Clin. Investig. 2021, 131, e146788. [Google Scholar] [CrossRef]
  5. Shoelson, S.E. Inflammation and Insulin Resistance. J. Clin. Investig. 2006, 116, 1793–1801. [Google Scholar] [CrossRef]
  6. Arnett, D.K.; Blumenthal, R.S.; Albert, M.A.; Buroker, A.B.; Goldberger, Z.D.; Hahn, E.J.; Himmelfarb, C.D.; Khera, A.; Lloyd-Jones, D.; McEvoy, J.W.; et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019, 140, e596–e646. [Google Scholar] [CrossRef]
  7. Colberg, S.R.; Sigal, R.J.; Yardley, J.E.; Riddell, M.C.; Dunstan, D.W.; Dempsey, P.C.; Horton, E.S.; Castorino, K.; Tate, D.F. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016, 39, 2065–2079. [Google Scholar] [CrossRef]
  8. Solomon, T.P.J.; Haus, J.M.; Kelly, K.R.; Rocco, M.; Kashyap, S.R.; Kirwan, J.P. Improved Pancreatic β-Cell Function in Type 2 Diabetic Patients after Lifestyle-Induced Weight Loss Is Related to Glucose-Dependent Insulinotropic Polypeptide. Diabetes Care 2010, 33, 1561–1566. [Google Scholar] [CrossRef]
  9. Dela, F.; von Linstow, M.E.; Joensen Mikines, K.; Galbo, H. Physical Training May Enhance-Cell Function in Type 2 Diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287, 1024–1031. [Google Scholar] [CrossRef]
  10. Coomans de Brachène, A.; Scoubeau, C.; Musuaya, A.E.; Costa-Junior, J.M.; Castela, A.; Carpentier, J.; Faoro, V.; Klass, M.; Cnop, M.; Eizirik, D.L. Exercise as a Non-Pharmacological Intervention to Protect Pancreatic Beta Cells in Individuals with Type 1 and Type 2 Diabetes. Diabetologia 2023, 66, 450–460. [Google Scholar] [CrossRef]
  11. Curran, M.; Drayson, M.T.; Andrews, R.C.; Zoppi, C.; Barlow, J.P.; Solomon, T.P.J.; Narendran, P. The Benefits of Physical Exercise for the Health of the Pancreatic β-Cell: A Review of the Evidence. Exp. Physiol. 2020, 105, 579–589. [Google Scholar] [CrossRef] [PubMed]
  12. Paula, F.M.M.; Leite, N.C.; Vanzela, E.C.; Kurauti, M.A.; Freitas-Dias, R.; Carneiro, E.M.; Boschero, A.C.; Zoppi, C.C. Exercise Increases Pancreatic Β-cell Viability in a Model of Type 1 Diabetes through IL-6 Signaling. FASEB J. 2015, 29, 1805–1816. [Google Scholar] [CrossRef] [PubMed]
  13. Paula, F.M.M.; Leite, N.C.; Borck, P.C.; Freitas-Dias, R.; Cnop, M.; Chacon-Mikahil, M.P.T.; Cavaglieri, C.R.; Marchetti, P.; Boschero, A.C.; Zoppi, C.C.; et al. Exercise Training Protects Human and Rodent β Cells against Endoplasmic Reticulum Stress and Apoptosis. FASEB J. 2018, 32, 1524–1536. [Google Scholar] [CrossRef]
  14. Thomas, D.; Elliott, E.J.; Naughton, G.A. Exercise for Type 2 Diabetes Mellitus. Cochrane Database Syst. Rev. 2006, 2009, CD002968. [Google Scholar] [CrossRef] [PubMed]
  15. Boulé, N.G.; Haddad, E.; Kenny, G.P.; Wells, G.A.; Sigal, R.J. Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus. JAMA 2001, 286, 1218. [Google Scholar] [CrossRef]
  16. Snowling, N.J.; Hopkins, W.G. Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients. Diabetes Care 2006, 29, 2518–2527. [Google Scholar] [CrossRef] [PubMed]
  17. Chudyk, A.; Petrella, R.J. Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes. Diabetes Care 2011, 34, 1228–1237. [Google Scholar] [CrossRef]
  18. Ried-Larsen, M.; Johansen, M.Y.; MacDonald, C.S.; Hansen, K.B.; Christensen, R.; Wedell-Neergaard, A.S.; Pilmark, N.S.; Langberg, H.; Vaag, A.A.; Pedersen, B.K.; et al. Type 2 Diabetes Remission 1 Year after an Intensive Lifestyle Intervention: A Secondary Analysis of a Randomized Clinical Trial. Diabetes Obes. Metab. 2019, 21, 2257–2266. [Google Scholar] [CrossRef]
  19. Ades, P.A.; Savage, P.D.; Marney, A.M.; Harvey, J.; Evans, K.A. Remission of Recently Diagnosed Type 2 Diabetes Mellitus with Weight Loss and Exercise. J. Cardiopulm. Rehabil. Prev. 2015, 35, 193–197. [Google Scholar] [CrossRef]
  20. Gregg, E.W.; Chen, H.; Wagenknecht, L.E.; Clark, J.M.; Delahanty, L.M.; Bantle, J.; Pownall, H.J.; Johnson, K.C.; Safford, M.M.; Kitabchi, A.E.; et al. Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes. JAMA 2012, 308, 2489. [Google Scholar] [CrossRef]
  21. Pelliccia, A.; Sharma, S.; Gati, S.; Bäck, M.; Börjesson, M.; Caselli, S.; Collet, J.-P.; Corrado, D.; Drezner, J.A.; Halle, M.; et al. 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease. Eur. Heart J. 2021, 42, 17–96. [Google Scholar] [CrossRef] [PubMed]
  22. Church, T.S.; Blair, S.N.; Cocreham, S.; Johannsen, N.; Johnson, W.; Kramer, K.; Mikus, C.R.; Myers, V.; Nauta, M.; Rodarte, R.Q.; et al. Effects of Aerobic and Resistance Training on Hemoglobin A 1c Levels in Patients With Type 2 Diabetes. JAMA 2010, 304, 2253. [Google Scholar] [CrossRef] [PubMed]
  23. Kanaley, J.A.; Colberg, S.R.; Corcoran, M.H.; Malin, S.K.; Rodriguez, N.R.; Crespo, C.J.; Kirwan, J.P.; Zierath, J.R. Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. In Proceedings of the Medicine and Science in Sports and Exercise, Northfield, IL, USA, 1 February 2022; Volume 54, pp. 353–368. [Google Scholar]
  24. Goodwin, M.L. Blood Glucose Regulation during Prolonged, Submaximal, Continuous Exercise: A Guide for Clinicians. J. Diabetes Sci. Technol. 2010, 4, 694–705. [Google Scholar] [CrossRef] [PubMed]
  25. Di Giuseppe, G.; Ciccarelli, G.; Cefalo, C.M.; Cinti, F.; Moffa, S.; Impronta, F.; Capece, U.; Pontecorvi, A.; Giaccari, A.; Mezza, T. Prediabetes: How Pathophysiology Drives Potential Intervention on a Subclinical Disease with Feared Clinical Consequences. Minerva Endocrinol. 2021, 46, 272–292. [Google Scholar] [CrossRef] [PubMed]
  26. DeFronzo, R.A.; Abdul-Ghani, M.A. Preservation of β-Cell Function: The Key to Diabetes Prevention. J. Clin. Endocrinol. Metab. 2011, 96, 2354–2366. [Google Scholar] [CrossRef]
  27. Soldovieri, L.; Di Giuseppe, G.; Ciccarelli, G.; Quero, G.; Cinti, F.; Brunetti, M.; Nista, E.C.; Gasbarrini, A.; Alfieri, S.; Pontecorvi, A.; et al. An Update on Pancreatic Regeneration Mechanisms: Searching for Paths to a Cure for Type 2 Diabetes. Mol. Metab. 2023, 74, 101754. [Google Scholar] [CrossRef] [PubMed]
  28. Lv, C.; Sun, Y.; Zhang, Z.Y.; Aboelela, Z.; Qiu, X.; Meng, Z.-X. β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions. J. Mol. Cell Biol. 2022, 14, mjac046. [Google Scholar] [CrossRef]
  29. Brusco, N.; Sebastiani, G.; Di Giuseppe, G.; Licata, G.; Grieco, G.E.; Fignani, D.; Nigi, L.; Formichi, C.; Aiello, E.; Auddino, S.; et al. Intra-Islet Insulin Synthesis Defects Are Associated with Endoplasmic Reticulum Stress and Loss of Beta Cell Identity in Human Diabetes. Diabetologia 2023, 66, 354–366. [Google Scholar] [CrossRef]
  30. Bloem, C.J.; Chang, A.M. Short-Term Exercise Improves β-Cell Function and Insulin Resistance in Older People with Impaired Glucose Tolerance. J. Clin. Endocrinol. Metab. 2008, 93, 387–392. [Google Scholar] [CrossRef]
  31. Croymans, D.M.; Paparisto, E.; Lee, M.M.; Brandt, N.; Le, B.K.; Lohan, D.; Lee, C.C.; Roberts, C.K. Resistance Training Improves Indices of Muscle Insulin Sensitivity and β-Cell Function in Overweight/Obese, Sedentary Young Men. J. Appl. Physiol. 2013, 115, 1245–1253. [Google Scholar] [CrossRef]
  32. Dela, F.; Stallknecht, B. Effect of Physical Training on Insulin Secretion and Action in Skeletal Muscle and Adipose Tissue of First-Degree Relatives of Type 2 Diabetic Patients. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E80–E91. [Google Scholar] [CrossRef] [PubMed]
  33. Hordern, M.D.; Cooney, L.M.; Beller, E.M.; Prins, J.B.; Marwick, T.H.; Coombes, J.S. Determinants of Changes in Blood Glucose Response to Short-Term Exercise Training in Patients with Type 2 Diabetes. Clin. Sci. 2008, 115, 273–281. [Google Scholar] [CrossRef] [PubMed]
  34. Boulé, N.G.; John Weisnagel, S.; Lakka, T.A.; Tremblay, A.; Bergman, R.N.; Rankinen, T.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H.; Rao, D.; et al. Effects of Exercise Training on Glucose Homeostasis the HERITAGE Family Study; Diabetes Care: Sainte-Foy, QC, Canada, 2005. [Google Scholar]
  35. Solomon, T.P.J.; Malin, S.K.; Karstoft, K.; Kashyap, S.R.; Haus, J.M.; Kirwan, J.P. Pancreatic β-Cell Function Is a Stronger Predictor of Changes in Glycemic Control after an Aerobic Exercise Intervention than Insulin Sensitivity. J. Clin. Endocrinol. Metab. 2013, 98, 4176–4186. [Google Scholar] [CrossRef] [PubMed]
  36. He, Y.; Feng, Y.; Shi, J.; Tang, H.; Chen, L.; Lou, Q. Β-Cell Function and Body Mass Index Are Predictors of Exercise Response in Elderly Patients with Prediabetes. J. Diabetes Investig. 2022, 13, 1253–1261. [Google Scholar] [CrossRef] [PubMed]
  37. Malin, S.K.; Solomon, T.P.J.; Blaszczak, A.; Finnegan, S.; Filion, J.; Kirwan, J.P. Pancreatic β-Cell Function Increases in a Linear Dose-Response Manner Following Exercise Training in Adults with Prediabetes. Am. J. Physiol. Endocrinol. Metab. 2013, 305, E1248–E1254. [Google Scholar] [CrossRef] [PubMed]
  38. Bacchi, E.; Negri, C.; Zanolin, M.E.; Milanese, C.; Faccioli, N.; Trombetta, M.; Zoppini, G.; Cevese, A.; Bonadonna, R.C.; Schena, F.; et al. Metabolic Effects of Aerobic Training and Resistance Training in Type 2 Diabetic Subjects. Diabetes Care 2012, 35, 676–682. [Google Scholar] [CrossRef]
  39. Lee, S.; Bacha, F.; Hannon, T.; Kuk, J.L.; Boesch, C.; Arslanian, S. Effects of Aerobic Versus Resistance Exercise Without Caloric Restriction on Abdominal Fat, Intrahepatic Lipid, and Insulin Sensitivity in Obese Adolescent Boys. Diabetes 2012, 61, 2787–2795. [Google Scholar] [CrossRef]
  40. Slentz, C.A.; Tanner, C.J.; Bateman, L.A.; Durheim, M.T.; Huffman, K.M.; Houmard, J.A.; Kraus, W.E. Effects of Exercise Training Intensity on Pancreatic β-Cell Function. Diabetes Care 2009, 32, 1807–1811. [Google Scholar] [CrossRef]
  41. AbouAssi, H.; Slentz, C.A.; Mikus, C.R.; Tanner, C.J.; Bateman, L.A.; Willis, L.H.; Shields, A.T.; Piner, L.W.; Penry, L.E.; Kraus, E.A.; et al. The Effects of Aerobic, Resistance, and Combination Training on Insulin Sensitivity and Secretion in Overweight Adults from STRRIDE AT/RT: A Randomized Trial. J. Appl. Physiol. 2015, 118, 1474–1482. [Google Scholar] [CrossRef]
  42. Madsen, S.M.; Thorup, A.C.; Overgaard, K.; Jeppesen, P.B. High Intensity Interval Training Improves Glycaemic Control and Pancreatic β Cell Function of Type 2 Diabetes Patients. PLoS ONE 2015, 10, 0133286. [Google Scholar] [CrossRef]
  43. Nieuwoudt, S.; Fealy, C.E.; Foucher, J.A.; Scelsi, A.R.; Malin, S.K.; Pagadala, M.; Rocco, M.; Burguera, B.; Kirwan, J.P. Functional High-Intensity Training Improves Pancreatic β-Cell Function in Adults with Type 2 Diabetes. Am. J. Physiol. Endocrinol. Metab. 2017, 313, E314–E320. [Google Scholar] [CrossRef] [PubMed]
  44. Lorenzo, C.; Wagenknecht, L.E.; Rewers, M.J.; Karter, A.J.; Bergman, R.N.; Hanley, A.J.G.; Haffner, S.M. Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes. Diabetes Care 2010, 33, 2098–2103. [Google Scholar] [CrossRef] [PubMed]
  45. Utzschneider, K.M.; Prigeon, R.L.; Faulenbach, M.V.; Tong, J.; Carr, D.B.; Boyko, E.J.; Leonetti, D.L.; McNeely, M.J.; Fujimoto, W.Y.; Kahn, S.E. Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels. Diabetes Care 2009, 32, 335–341. [Google Scholar] [CrossRef] [PubMed]
  46. Retnakaran, R.; Qi, Y.; Goran, M.I.; Hamilton, J.K. Evaluation of Proposed Oral Disposition Index Measures in Relation to the Actual Disposition Index. Diabet. Med. 2009, 26, 1198–1203. [Google Scholar] [CrossRef] [PubMed]
  47. Michishita, R.; Shono, N.; Kasahara, T.; Tsuruta, T. Effects of Low Intensity Exercise Therapy on Early Phase Insulin Secretion in Overweight Subjects with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus. Diabetes Res. Clin. Pract. 2008, 82, 291–297. [Google Scholar] [CrossRef] [PubMed]
  48. Solomon, T.P.J.; Knudsen, S.H.; Karstoft, K.; Winding, K.; Holst, J.J.; Pedersen, B.K. Examining the Effects of Hyperglycemia on Pancreatic Endocrine Function in Humans: Evidence for in Vivo Glucotoxicity. J. Clin. Endocrinol. Metab. 2012, 97, 4682–4691. [Google Scholar] [CrossRef]
  49. Fritsche, A.; Wagner, R.; Heni, M.; Kantartzis, K.; Machann, J.; Schick, F.; Lehmann, R.; Peter, A.; Dannecker, C.; Fritsche, L.; et al. Different Effects of Lifestyle Intervention in High-and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS). Diabetes 2021, 70, 2785–2795. [Google Scholar] [CrossRef]
  50. Willis, L.H.; Slentz, C.A.; Bateman, L.A.; Shields, A.T.; Piner, L.W.; Bales, C.W.; Houmard, J.A.; Kraus, W.E. Effects of Aerobic and/or Resistance Training on Body Mass and Fat Mass in Overweight or Obese Adults. J. Appl. Physiol. 2012, 113, 1831–1837. [Google Scholar] [CrossRef]
  51. Lee, D.; Sui, X.; Artero, E.G.; Lee, I.-M.; Church, T.S.; McAuley, P.A.; Stanford, F.C.; Kohl, H.W.; Blair, S.N. Long-Term Effects of Changes in Cardiorespiratory Fitness and Body Mass Index on All-Cause and Cardiovascular Disease Mortality in Men. Circulation 2011, 124, 2483–2490. [Google Scholar] [CrossRef]
  52. Kadoglou, N.P.E.; Iliadis, F.; Angelopoulou, N.; Perrea, D.; Ampatzidis, G.; Liapis, C.D.; Alevizos, M. The Anti-Inflammatory Effects of Exercise Training in Patients with Type 2 Diabetes Mellitus. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14, 837–843. [Google Scholar] [CrossRef]
  53. Slentz, C.A.; Bateman, L.A.; Willis, L.H.; Granville, E.O.; Piner, L.W.; Samsa, G.P.; Setji, T.L.; Muehlbauer, M.J.; Huffman, K.M.; Bales, C.W.; et al. Effects of Exercise Training Alone vs a Combined Exercise and Nutritional Lifestyle Intervention on Glucose Homeostasis in Prediabetic Individuals: A Randomised Controlled Trial. Diabetologia 2016, 59, 2088–2098. [Google Scholar] [CrossRef]
  54. Winnick, J.J.; Sherman, W.M.; Habash, D.L.; Stout, M.B.; Failla, M.L.; Belury, M.A.; Schuster, D.P. Short-Term Aerobic Exercise Training in Obese Humans with Type 2 Diabetes Mellitus Improves Whole-Body Insulin Sensitivity through Gains in Peripheral, Not Hepatic Insulin Sensitivity. J. Clin. Endocrinol. Metab. 2008, 93, 771–778. [Google Scholar] [CrossRef] [PubMed]
  55. Castaneda, C.; Layne, J.E.; Munoz-Orians, L.; Gordon, P.L.; Walsmith, J.; Foldvari, M.; Roubenoff, R.; Tucker, K.L.; Nelson, M.E. A Randomized Controlled Trial of Resistance Exercise Training to Improve Glycemic Control in Older Adults With Type 2 Diabetes. Diabetes Care 2002, 25, 2335–2341. [Google Scholar] [CrossRef] [PubMed]
  56. Sigal, R.J.; Kenny, G.P.; Boulé, N.G.; Wells, G.A.; Prud’homme, D.; Fortier, M.; Reid, R.D.; Tulloch, H.; Coyle, D.; Phillips, P.; et al. Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes. Ann. Intern. Med. 2007, 147, 357. [Google Scholar] [CrossRef] [PubMed]
  57. Cuff, D.J.; Meneilly, G.S.; Martin, A.; Ignaszewski, A.; Tildesley, H.D.; Frohlich, J.J. Effective Exercise Modality to Reduce Insulin Resistance in Women With Type 2 Diabetes. Diabetes Care 2003, 26, 2977–2982. [Google Scholar] [CrossRef] [PubMed]
  58. Schwingshackl, L.; Missbach, B.; Dias, S.; König, J.; Hoffmann, G. Impact of Different Training Modalities on Glycaemic Control and Blood Lipids in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Diabetologia 2014, 57, 1789–1797. [Google Scholar] [CrossRef]
  59. Herriott, M.T.; Colberg, S.R.; Parson, H.K.; Nunnold, T.; Vinik, A.I. Effects of 8 Weeks of Flexibility and Resistance Training in Older Adults With Type 2 Diabetes. Diabetes Care 2004, 27, 2988–2989. [Google Scholar] [CrossRef]
  60. Morrison, S.; Colberg, S.R.; Mariano, M.; Parson, H.K.; Vinik, A.I. Balance Training Reduces Falls Risk in Older Individuals With Type 2 Diabetes. Diabetes Care 2010, 33, 748–750. [Google Scholar] [CrossRef]
  61. Morrison, S.; Simmons, R.; Colberg, S.R.; Parson, H.K.; Vinik, A.I. Supervised Balance Training and Wii Fit–Based Exercises Lower Falls Risk in Older Adults With Type 2 Diabetes. J. Am. Med. Dir. Assoc. 2018, 19, 185.e7–185.e13. [Google Scholar] [CrossRef]
  62. Melo, K.C.B.; Araújo, F.d.S.; Cordeiro Júnior, C.C.M.; de Andrade, K.T.P.; Moreira, S.R. Pilates Method Training: Functional and Blood Glucose Responses of Older Women With Type 2 Diabetes. J. Strength Cond. Res. 2020, 34, 1001–1007. [Google Scholar] [CrossRef]
  63. Cui, J.; Yan, J.-H.; Yan, L.-M.; Pan, L.; Le, J.-J.; Guo, Y.-Z. Effects of Yoga in Adults with Type 2 Diabetes Mellitus: A Meta-Analysis. J. Diabetes Investig. 2017, 8, 201–209. [Google Scholar] [CrossRef] [PubMed]
  64. Thind, H.; Lantini, R.; Balletto, B.L.; Donahue, M.L.; Salmoirago-Blotcher, E.; Bock, B.C.; Scott-Sheldon, L.A.J. The Effects of Yoga among Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Prev. Med. 2017, 105, 116–126. [Google Scholar] [CrossRef] [PubMed]
  65. Jelleyman, C.; Yates, T.; O’Donovan, G.; Gray, L.J.; King, J.A.; Khunti, K.; Davies, M.J. The Effects of High-Intensity Interval Training on Glucose Regulation and Insulin Resistance: A Meta-Analysis. Obes. Rev. 2015, 16, 942–961. [Google Scholar] [CrossRef] [PubMed]
  66. Smith, L.E.; Van Guilder, G.P.; Dalleck, L.C.; Harris, N.K. The Effects of High-Intensity Functional Training on Cardiometabolic Risk Factors and Exercise Enjoyment in Men and Women with Metabolic Syndrome: Study Protocol for a Randomized, 12-Week, Dose-Response Trial. Trials 2022, 23, 182. [Google Scholar] [CrossRef]
  67. Fealy, C.E.; Nieuwoudt, S.; Foucher, J.A.; Scelsi, A.R.; Malin, S.K.; Pagadala, M.; Cruz, L.A.; Li, M.; Rocco, M.; Burguera, B.; et al. Functional High-Intensity Exercise Training Ameliorates Insulin Resistance and Cardiometabolic Risk Factors in Type 2 Diabetes. Exp. Physiol. 2018, 103, 985–994. [Google Scholar] [CrossRef]
  68. Langlois, A.; Forterre, A.; Pinget, M.; Bouzakri, K. Impact of Moderate Exercise on Fatty Acid Oxidation in Pancreatic β-Cells and Skeletal Muscle. J. Endocrinol. Investig. 2021, 44, 1815–1825. [Google Scholar] [CrossRef]
  69. Korkiakangas, E.E.; Alahuhta, M.A.; Laitinen, J.H. Barriers to Regular Exercise among Adults at High Risk or Diagnosed with Type 2 Diabetes: A Systematic Review. Health Promot. Int. 2009, 24, 416–427. [Google Scholar] [CrossRef]
  70. Blackwell, D.L.; Clarke, T.C. State Variation in Meeting the 2008 Federal Guidelines for Both Aerobic and Muscle-Strengthening Activities through Leisure-Time Physical Activity among Adults Aged 18–64: United States, 2010–2015; United States, 2008. Available online: https://www.govinfo.gov/app/details/GOVPUB-HE20-PURL-gpo108937 (accessed on 6 September 2023).
  71. Jarvie, J.L.; Pandey, A.; Ayers, C.R.; McGavock, J.M.; Sénéchal, M.; Berry, J.D.; Patel, K.V.; McGuire, D.K. Aerobic Fitness and Adherence to Guideline-Recommended Minimum Physical Activity among Ambulatory Patients with Type 2 Diabetes Mellitus. Diabetes Care 2019, 42, 1333–1339. [Google Scholar] [CrossRef]
  72. Di Loreto, C.; Fanelli, C.; Lucidi, P.; Murdolo, G.; De Cicco, A.; Parlanti, N.; Ranchelli, A.; Fatone, C.; Taglioni, C.; Santeusanio, F.; et al. Make Your Diabetic Patients Walk. Diabetes Care 2005, 28, 1295–1302. [Google Scholar] [CrossRef]
  73. Balducci, S.; Zanuso, S.; Cardelli, P.; Salvi, L.; Bazuro, A.; Pugliese, L.; Maccora, C.; Iacobini, C.; Conti, F.G.; Nicolucci, A.; et al. Effect of High- versus Low-Intensity Supervised Aerobic and Resistance Training on Modifiable Cardiovascular Risk Factors in Type 2 Diabetes; The Italian Diabetes and Exercise Study (IDES). PLoS ONE 2012, 7, e49297. [Google Scholar] [CrossRef]
  74. Gibala, M.J. High-Intensity Interval Training: A Time-Efficient Strategy for Health Promotion? Curr. Sport. Med. Rep. 2007, 6, 211–213. [Google Scholar] [CrossRef]
  75. Davis, C.L.; Pollock, N.K.; Waller, J.L.; Allison, J.D.; Dennis, B.A.; Bassali, R.; Meléndez, A.; Boyle, C.A.; Gower, B.A. Exercise Dose and Diabetes Risk in Overweight and Obese Children: A Randomized Controlled Trial. JAMA 2012, 308, 1103–1112. [Google Scholar] [CrossRef]
  76. Nesti, L.; Pugliese, N.R.; Sciuto, P.; Natali, A. Type 2 Diabetes and Reduced Exercise Tolerance: A Review of the Literature through an Integrated Physiology Approach. Cardiovasc. Diabetol. 2020, 19, 134. [Google Scholar] [CrossRef] [PubMed]
  77. Regensteiner, J.G.; Bauer, T.A.; Huebschmann, A.G.; Herlache, L.; Weinberger, H.D.; Wolfel, E.E.; Reusch, J.E.B. Sex Differences in the Effects of Type 2 Diabetes on Exercise Performance. Med. Sci. Sport. Exerc. 2015, 47, 58–65. [Google Scholar] [CrossRef]
  78. American Diabetes Association. 5. Facilitating Behavior Change and Well-Being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021, 44, S53–S72. [Google Scholar] [CrossRef] [PubMed]
  79. American Diabetes Association. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021, 44, S100–S110. [Google Scholar] [CrossRef]
  80. Franz, M.J.; MacLeod, J.; Evert, A.; Brown, C.; Gradwell, E.; Handu, D.; Reppert, A.; Robinson, M. Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Systematic Review of Evidence for Medical Nutrition Therapy Effectiveness and Recommendations for Integration into the Nutrition Care Process. J. Acad. Nutr. Diet. 2017, 117, 1659–1679. [Google Scholar] [CrossRef]
  81. Sievenpiper, J.L.; Chan, C.B.; Dworatzek, P.D.; Freeze, C.; Williams, S.L. Nutrition Therapy. Can. J. Diabetes 2018, 42, S64–S79. [Google Scholar] [CrossRef]
  82. Ojo, O. Dietary Intake and Type 2 Diabetes. Nutrients 2019, 11, 2177. [Google Scholar] [CrossRef]
  83. Petroni, M.L.; Brodosi, L.; Marchignoli, F.; Sasdelli, A.S.; Caraceni, P.; Marchesini, G.; Ravaioli, F. Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges. Nutrients 2021, 13, 2748. [Google Scholar] [CrossRef]
  84. Vitale, M.; Masulli, M.; Calabrese, I.; Rivellese, A.; Bonora, E.; Signorini, S.; Perriello, G.; Squatrito, S.; Buzzetti, R.; Sartore, G.; et al. Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study. Nutrients 2018, 10, 1067. [Google Scholar] [CrossRef] [PubMed]
  85. Snetselaar, L.G.; de Jesus, J.M.; DeSilva, D.M.; Stoody, E.E. Dietary Guidelines for Americans, 2020–2025. Nutr. Today 2021, 56, 287–295. [Google Scholar] [CrossRef]
  86. Chester, B.; Babu, J.R.; Greene, M.W.; Geetha, T. The Effects of Popular Diets on Type 2 Diabetes Management. Diabetes Metab. Res. Rev. 2019, 35, e3188. [Google Scholar] [CrossRef] [PubMed]
  87. Saslow, L.R.; Mason, A.E.; Kim, S.; Goldman, V.; Ploutz-Snyder, R.; Bayandorian, H.; Daubenmier, J.; Hecht, F.M.; Moskowitz, J.T. An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial. J. Med. Internet Res. 2017, 19, e36. [Google Scholar] [CrossRef]
  88. Crupi, A.N.; Haase, J.; Brandhorst, S.; Longo, V.D. Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease. Curr. Diabetes Rep. 2020, 20, 83. [Google Scholar] [CrossRef]
  89. Hansen, D.; De Strijcker, D.; Calders, P. Impact of Endurance Exercise Training in the Fasted State on Muscle Biochemistry and Metabolism in Healthy Subjects: Can These Effects Be of Particular Clinical Benefit to Type 2 Diabetes Mellitus and Insulin-Resistant Patients? Sports Med. 2017, 47, 415–428. [Google Scholar] [CrossRef]
  90. Qian, J.; Xiao, Q.; Walkup, M.P.; Coday, M.; Erickson, M.L.; Unick, J.; Jakicic, J.M.; Hu, K.; Scheer, F.A.J.L.; Middelbeek, R.J.W. Association of Timing of Moderate-to-Vigorous Physical Activity With Changes in Glycemic Control Over 4 Years in Adults With Type 2 Diabetes From the Look AHEAD Trial. Diabetes Care 2023, 46, 1417–1424. [Google Scholar] [CrossRef]
Table 1. Clinical studies evaluating the effects of different patterns of PA on β-cell function and glucose homeostasis.
Table 1. Clinical studies evaluating the effects of different patterns of PA on β-cell function and glucose homeostasis.
Refs.YearPopulationInterventionDuration
(Weeks)		Frequency
(Sessions/Week)		Intensity
(min/Session)		Dietary
Intervention		Effects on
β-Cell Function		Additional Effects on
Glucose Homeostasis
Solomon [8]2010NGT obese subjectsAT12560✔️↓ OGTT-derived IS
(not significant when corrected for IR)		-
T2DM obese subjectsAT12560✔️↑ OGTT-derived IS-
Dela [9]2004T2DM subjectsAT
vs.
no exercise		12530–40✕↑ β-cell secretory capacity in subjects with preserved β-cell function at baseline-
Bloem [30]2008IGT overweight/obese subjectsAT1760✕↓ AIRg
↑ DI		↑ Insulin sensitivity
Croymans [31]2013Non-diabetic
overweight/obese subjects		RT12360✕↑ DI↑ Insulin sensitivity
(OGTT-derived mISI)
↓ glucose AUCOGTT
↓ insulin AUCOGTT
Dela [32]2010Normal weight or overweight first-degree relatives of T2DM subjectsAT
(endurance)		12645✕=glucose-stimulated IS↑ glucose-mediated GU
Control groupAT
(endurance)		12645✕=glucose-stimulated IS↑ insulin-mediated GU
↑ glucose-mediated GU
Hordern [33]2008T2DM overweight/obese subjectsAT + RT4380–85✕=HOMA-βBaseline glucose and HbA1c were predictors of
↓ blood glucose after intervention
Boulè [34]2005Non-diabetic
overweight/obese subjects		AT
(endurance)		20330–50✕↑ AIRg (in the quartile with the worst baseline GT)
↓ AIRg (in the quartile with the better baseline GT)		-
Solomon [35]2013IGT and T2DM
overweight/obese subjects		AT12-164–560✕↑ 1st and 2nd-phase DI-
He [36]2016Prediabetic
normal weight and overweight subjects		AT
vs.
RT
vs.
control		93350–60✕↓ HOMA-β
(in both groups vs control)
Baseline HOMA-β, HbA1c and BMI were predictors of positive β-cell response to training		↓ glucose levels
↓ HbA1c
↓ HOMA-IR
(in both groups vs control)
Malin [37]2013Prediabetic obese subjectsAT12560✔️↑ 1st and 2nd-phase DI
(related to exercise-dose)		-
Bacchi [38]2012Overweight T2DM patientsAT + RT16360✔️No major effectsBaseline HbA1c was predictor of changes in HbA1c after intervention
Lee [39]2012Non-diabetic obese adolescent subjectsAT
vs.
RT
vs.
no-exercise		12360✕=IS at hyperglycemic clamp
=DI at hyperglycemic clamp		↑ Insulin sensitivity
only in RT group
=GT
Slentz [40]2009Non-diabetic overweight/obese subjectsAT
(at different amount/intensity)
vs.
no exercise		32VariableVariable✕↑ DI
(moderate-intensity group displayed major improvements in the DI)		-
AbouAssi [41]2015Non-diabetic overweight/obese subjectsAT
vs.
RT
vs.
AT + RT		32VariableVariable✕↑ DI
↑ glucose effectiveness
(in the AT + AR group compared to AT and AR groups alone)		-
Madsen [42]2015T2DM overweight/obese subjectsHIIT8330✕↑ DI
↓ HOMA-β		↓ glucose levels
↓ HbA1c
↓ HOMA-IR
Non-diabetic subjectsHIIT8330✕--
Nieuwoudt [43]2017T2DM
subjects		F-HIT6310–20✕↑ DI
=1st and 2nd-phase IS		-
Key and abbreviations: ↑: increased; ↓: decreased; =: no changes; ✔️: yes; ✕: no; AT: aerobic training; RT: resistance training; HIIT: high-intensity interval training; F-HIT: functional high-intensity training; NGT: normal glucose-tolerant; T2DM: type 2 diabetes mellitus; IGT: impaired glucose-tolerant; IS: insulin secretion; OGTT: oral glucose tolerance test; AIRg: acute insulin response to glucose; DI: disposition index; mISI: muscle insulin sensitivity index; AUCOGTT: OGTT-derived area under the curve; GU: glucose uptake; GT: glucose tolerance; HbA1c: glycosylated hemoglobin; HOMA-IR: homeostatic model assessment for insulin resistance; HOMA- β: homeostatic model assessment for β-cell function.
Table 2. Type of physical exercise for adults with T2DM.
Table 2. Type of physical exercise for adults with T2DM.
Type of ExerciseDescriptionIntensityFrequencyDurationProven BenefitsAdditional Specification
Aerobic TrainingRhythmic and repetitive PA that uses large muscle groups, e.g., running, cycling, swimming, dancing, joggingModerate
(55–74% HRmax)
or
Vigorous
(75–95% HRmax)		5–7 d/week with no more than two consecutive days between boutsAt least 30′/session for
≥150′/week of moderate activity
or ≥75′/week of vigorous activity
(or an equivalent combination of moderate- and vigorous-intensity, preferably spread throughout the week).		↓ Glycemia with fewer daily hyperglycemic excursions
↓ HbA1c
↑ Insulin sensitivity
↓ Blood lipids
↓ BP
↑ Fitness levels, even without weight loss		-
Resistance TrainingShort-term repetition exercises performed using external resistance tools like dumbbells, kettlebells, and barbells, or using body weight, weight machines, or elastic resistance bandsModerate (50–69% of 1-RM)
or
Vigorous (70–85% of 1-RM)		2–3 d/week on non-consecutive days10–15 repetitions/set with 1–3 sets per type of specific exercise↑ Strength
↑ Bone mineral density
↑ Lean mass
↓ BP
↓ Blood lipids
↑ Insulin sensitivity
↓ HbA1c		-
PilatesSpecific targeted exercises to improve strength, flexibility, and posture, with particular focus on the coreLight≥2–3 d/week-↑ Blood glucose management
↑ Functional capacity		For patients with low levels of fitness and insufficient balance
YogaBreath, movement, and meditation to unite mind, body, and spiritLight≥2–3 d/week-↓ HbA1c
↓ Blood lipids
↑ Improvement body composition		For patients with low levels of fitness and insufficient balance
BalanceFocuses on the ability to maintain proper posture and refers to exercises that are designed to improve and maintain balanceLight≥2–3 d/week--↓Risk of falls by improving balance and gait, even in adults with peripheral neuropathy
FlexibilityStretching and moving a joint through its range of motionLight≥2–3 d/week10″–30″ per
stretch (static or dynamic) group; 2–4 repetitions of each		-↑ Joint range-of-motion; facilitates participation in activities that require flexibility
HIIT
F-HIT		HIIT: repetitions of short intervals of vigorous aerobic training (running or cycling) alternating with a short period of active or passive recovery.
F-HIT: based on real-world situational exercises at a high intensity by combining resistance training, gymnastics (body weight), and aerobic exercise		Vigorous (75–95% HRmax) follow by active or passive recovery3 d/weekRepetitions of 10″–4′ of vigorous activity with 12″–5′ of active or passive recovery↑ Insulin sensitivity
↑ β-cell function in T2DM with preserved residual β-cell secretory capacity
↑ Fitness levels
↓ HbA1c
↓ BMI
↑ CGM		-
Key and abbreviations: ↑: increased; ↓: decreased; HIIT: high-intensity interval training; F-HIT: functional high-intensity training; T2DM: type 2 diabetes mellitus; HbA1c: glycosylated hemoglobin; 1-RM: 1-repetition maximum; HRmax: heart rate max; BMI: body mass index; CGM: continuous glucose monitoring; BP: blood pressure; PA: physical activity.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Di Murro, E.; Di Giuseppe, G.; Soldovieri, L.; Moffa, S.; Improta, I.; Capece, U.; Nista, E.C.; Cinti, F.; Ciccarelli, G.; Brunetti, M.; et al. Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function. Nutrients 2023, 15, 4202. https://doi.org/10.3390/nu15194202

AMA Style

Di Murro E, Di Giuseppe G, Soldovieri L, Moffa S, Improta I, Capece U, Nista EC, Cinti F, Ciccarelli G, Brunetti M, et al. Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function. Nutrients. 2023; 15(19):4202. https://doi.org/10.3390/nu15194202

Chicago/Turabian Style

Di Murro, Emanuela, Gianfranco Di Giuseppe, Laura Soldovieri, Simona Moffa, Ilaria Improta, Umberto Capece, Enrico Celestino Nista, Francesca Cinti, Gea Ciccarelli, Michela Brunetti, and et al. 2023. "Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function" Nutrients 15, no. 19: 4202. https://doi.org/10.3390/nu15194202

APA Style

Di Murro, E., Di Giuseppe, G., Soldovieri, L., Moffa, S., Improta, I., Capece, U., Nista, E. C., Cinti, F., Ciccarelli, G., Brunetti, M., Gasbarrini, A., Pontecorvi, A., Giaccari, A., & Mezza, T. (2023). Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function. Nutrients, 15(19), 4202. https://doi.org/10.3390/nu15194202

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop